Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Lise Matzke"'
Publikováno v:
Biopreservation and Biobanking. 20:75-83
Background: Tumor biobanks are a common research infrastructure. As a collection of biospecimens and annotated data collected to support a multitude of research projects, biobanks facilitate access...
Publikováno v:
Biopreservation and Biobanking. 19:250-257
Background: The permission to contact (PTC) platform is a useful mechanism to increase patient engagement and enrollment into biobanks. It provides biobanks with the ability to select specific pati...
Publikováno v:
Biopreservation and Biobanking. 19:98-100
Publikováno v:
Biopreservation and biobanking. 20(2)
Background: Over time, researchers' demand for increased quality and quantity of biospecimens has risen. However, quality is multifaceted, ranging from simple to complex, and comes at a cost. There...
Autor:
Peter H. Watson, Simon Dee, Jodi LeBlanc, Tamsin Tarling, Suzanne Vercauteren, Brent Gali, Lise Matzke
Publikováno v:
Biopreservation and biobanking. 20(2)
Biobanks are a critical piece of Research Infrastructure (RI). However, biobanks need to accept the reality of a life cycle for RIs. Until recently, strategies to sustain biobanks have been commonly focused on ways to maintain current operational mod
Publikováno v:
Biopreservation and Biobanking. 18:4-6
Publikováno v:
Biopreservation and Biobanking. 17:326-333
A substantial fraction of biomedical research depends on the reliability of human biospecimens but variations in sample manipulation during collection, processing, and storage can differentially alter molecular integrity and influence interpretation
Publikováno v:
Biopreservation and Biobanking. 17:219-229
Tumor biobanks have become critical components of the cancer research infrastructure. Consideration of how to place appropriate values on tumor biobanks is important for all stakeholders. At the level of individual biobanks, value is important in det
Autor:
Peter H. Watson, Lise Matzke
Publikováno v:
Biomarker Insights, Vol 15 (2020)
Biomarker Insights
Biomarker Insights
Biomarkers are critical tools that underpin precision medicine. However there has been slow progress and frequent failure of biomarker development. The root causes are multifactorial. Here, we focus on the need for fast, efficient, and reliable acces
Autor:
Anna Meredith, Brent Schacter, Alex Slotty, Lise Matzke, Tania Castillo-Pelayo, Sindy Babinszky, Daniel Simeon-Dubach, Marianne K. Henderson, Peter H. Watson
Publikováno v:
Biopreservation and Biobanking. 15:57-64
The notion of attributing user fees to researchers for biospecimens provided by biobanks has been discussed frequently in the literature. However, the considerations around how to attribute the cost for these biospecimens and data have, until recentl